Does haemodynamic optimisation, as guided by Oesophageal Doppler Monitoring, produce a greater reduction in complications and length of stay, if used intra-operatively, post-operatively or both?
| ISRCTN | ISRCTN47114813 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN47114813 |
| Secondary identifying numbers | N0051189167 |
- Submission date
- 28/09/2007
- Registration date
- 28/09/2007
- Last edited
- 04/09/2015
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Ms Annette Smith
Scientific
Scientific
Royal Sussex County Hospital
Eastern Road
Brighton
BN2 5BE
United Kingdom
Study information
| Study design | Randomised pilot study |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Hospital |
| Study type | Treatment |
| Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
| Scientific title | Does haemodynamic optimisation, as guided by Oesophageal Doppler Monitoring, produce a greater reduction in complications and length of stay, if used intra-operatively, post-operatively or both? |
| Study objectives | 1. Does haemodynamic optimisation, as guided by Oesophageal Doppler Monitoring (ODM), produce a greater reduction in complications and length of stay, if used intra-operatively, post-operatively or both? 2. Objective: To compare the use of ODM to guide fluid management and optimise haemodynamic status (maintaining blood/fluid volume within the bodies circulation and ensuring that the patients Blood Pressure and heart function is adequate to supply the other organs of the body), at different stages of the surgery: 2.1 During the operation 2.2 Immediately after the operation until the patient is weaned off the ventilator (breathing machine) 2.3 Combined during and immediately after the operation until weaned off the ventilator. The 3 groups will be compared to see which gives the greatest reduction in the length of hospital stay, from the operation date to the day of discharge. ODM uses a silicone probe inserted into the oesophagus to monitor heart function. It does this by measuring the velocity of the blood flow in the descending aorta (the main artery from the heart supplying the body). The information obtained can be used to guide fluid management in critically ill patients or during major surgery, in combination to the routine measures used of Blood Pressure (BP) pulse, urine output and blood loss. |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Surgery: Coronary artery bypass grafting (CABG) |
| Intervention | This will be a pilot study that will investigate/compare fluid optimisation of adult patients at different stages of their surgical experience. There will be three groups in the study: 1. Intra-operative fluid optimisation as guided by ODM. 2. Post-operative fluid optimisation as guided by ODM (until extubation/weaned off the ventilator). 3. Combined Intra and Post-operative fluid optimisation as guided by ODM (until extubation). An internet and journal database search of literature on the used of ODM as a guide to fluid optimisation found that it reduces hospital stay and post-operative complications. Most of the studies used ODM during the operation. One (involving patients having heart surgery) used ODM immediately after the operation. Therefore it would appear valid to investigate which provides the best outcome in terms of reduced hospital stay or whether a greater benefit is obtained by a combination of the two. The primary objective is to compare the three groups to see which one produces the best result in reducing length of hospital stay. The secondary objective is to compare post-operative complications, specifically that of post-operative nausea, arrhythmias and renal complications. Nausea or vomiting can be measured by the anti-emetics given on the drug chart or vomiting on the fluid chart. Arrhythmias will be measured by any arrhythmia that caused haemodynamic instability and to investigate renal complications the increase in the blood creatinine and urea from routine blood results will be analysed. The Doppler probes will be inserted in theatre during surgery by a consultant anaesthetist. This will mean that the nursing staff will not be aware which group the participant is in. The participants in group one will receive standard post-operative care when they arrive in the Intensive Care Unit (ICU). All participants will receive standard post-operative care once they have been extubated. A flow chart will be used both during the operation and until extubation (depending which group the participant is in), to guide the fluid optimisation. All patients are continuously monitored for heart rate/rhythm, blood pressure and central venous pressure. This is recorded hourly on the Intensive Care charts. Fluid loss and urine output are also recorded and monitored closely. The addition of the ODM and its readings will be recorded on the same observation chart. Readings prior to and after fluid is given will be documented as will the type of fluid (blood or artificial plasma). |
| Intervention type | Procedure/Surgery |
| Primary outcome measure | Not provided at time of registration |
| Secondary outcome measures | Not provided at time of registration |
| Overall study start date | 01/10/2006 |
| Completion date | 01/10/2007 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Sex | Both |
| Target number of participants | 21 |
| Key inclusion criteria | Participants will be adult patients who are to undergo Coronary Artery Bypass Grafting (CABG) or valve surgery for the first time, both male and female. There will be a minimum of 21 participants in the pilot study. The small number is due to time constraints and the need for staff training. The participants will be randomly assigned to one of the three groups. |
| Key exclusion criteria | Patients who have had previous surgery will not be considered as they are at increased risk of complications due to a number of factors. |
| Date of first enrolment | 01/10/2006 |
| Date of final enrolment | 01/10/2007 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Royal Sussex County Hospital
Brighton
BN2 5BE
United Kingdom
BN2 5BE
United Kingdom
Sponsor information
Record Provided by the NHSTCT Register - 2007 Update - Department of Health
Government
Government
The Department of Health, Richmond House, 79 Whitehall
London
SW1A 2NL
United Kingdom
| Phone | +44 (0)20 7307 2622 |
|---|---|
| dhmail@doh.gsi.org.uk | |
| Website | http://www.dh.gov.uk/Home/fs/en |
Funders
Funder type
Government
Brighton and Sussex University Hospitals NHS Trust (UK)
No information available
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
